Pancreatic Adenocarcinoma Locally Advanced

Also known as: Locally Advanced Pancreatic Adenocarcinoma

Drug	Drug Name	Drug Description
DB00441	Gemcitabine	A nucleoside metabolic inhibitor used as adjunct therapy in the treatment of certain types of ovarian cancer, non-small cell lung carcinoma, metastatic breast cancer, and as a single agent for pancreatic cancer.

Drug	Drug Name	Target	Type
DB00441	Gemcitabine	Ribonucleoside-diphosphate reductase large subunit	target
DB00441	Gemcitabine	UMP-CMP kinase	target
DB00441	Gemcitabine	Thymidylate synthase	target
DB00441	Gemcitabine	Cytidine deaminase	enzyme
DB00441	Gemcitabine	Deoxycytidine kinase	enzyme
DB00441	Gemcitabine	ATP-dependent translocase ABCB1	transporter
DB00441	Gemcitabine	ATP-binding cassette sub-family C member 10	transporter
DB00441	Gemcitabine	Equilibrative nucleoside transporter 1	transporter
DB00441	Gemcitabine	DNA	target
DB00441	Gemcitabine	Sodium/nucleoside cotransporter 1	transporter
DB00441	Gemcitabine	Equilibrative nucleoside transporter 2	transporter
DB00441	Gemcitabine	Solute carrier family 28 member 3	transporter
DB00441	Gemcitabine	Thymidine kinase 2, mitochondrial	enzyme
DB00441	Gemcitabine	UMP-CMP kinase	enzyme
DB00441	Gemcitabine	Nucleoside diphosphate kinase A	enzyme
DB00441	Gemcitabine	Ribonucleoside-diphosphate reductase subunit M2	target

Drug	Drug Name	Phase	Status	Count
DB15134	Fluoroazomycin arabinoside F-18	Not Available	Active Not Recruiting	1
DB00544	Fluorouracil	Not Available	Active Not Recruiting	1
DB00441	Gemcitabine	Not Available	Active Not Recruiting	1
DB00650	Leucovorin	Not Available	Active Not Recruiting	1
DB01229	Paclitaxel	Not Available	Active Not Recruiting	1
DB00441	Gemcitabine	0	Completed	1
DB13982	Lutetium Lu-177	0	Recruiting	1
DB01229	Paclitaxel	0	Completed	1
DB12001	Abemaciclib	1	Terminated	1
DB05812	Abiraterone	1	Terminated	1
DB08916	Afatinib	1	Terminated	1
DB00062	Albumin human	1	Completed	1
DB00062	Albumin human	1	Terminated	1
DB00023	Asparaginase Escherichia coli	1	Recruiting	1
DB09495	Avobenzone	1	Terminated	1
DB11105	Benzalkonium	1	Recruiting	1
DB00112	Bevacizumab	1	Terminated	1
DB01128	Bicalutamide	1	Terminated	1
DB00188	Bortezomib	1	Terminated	1
DB16741	Bortezomib D-mannitol	1	Terminated	1
DB06772	Cabazitaxel	1	Terminated	1
DB08875	Cabozantinib	1	Terminated	1
DB14730	Calaspargase pegol	1	Recruiting	1
DB01101	Capecitabine	1	Completed	1
DB01101	Capecitabine	1	Terminated	1
DB14531	Carbonate ion	1	Recruiting	1
DB00958	Carboplatin	1	Terminated	1
DB00482	Celecoxib	1	Terminated	1
DB05239	Cobimetinib	1	Recruiting	1
DB05239	Cobimetinib	1	Terminated	1
DB12483	Copanlisib	1	Terminated	1
DB08912	Dabrafenib	1	Terminated	1
DB11963	Dacomitinib	1	Terminated	1
DB12941	Darolutamide	1	Terminated	1
DB01254	Dasatinib	1	Terminated	1
DB00694	Daunorubicin	1	Terminated	1
DB00997	Doxorubicin	1	Terminated	1
DB11714	Durvalumab	1	Terminated	1
DB13874	Enasidenib	1	Terminated	1
DB11986	Entrectinib	1	Terminated	1
DB08899	Enzalutamide	1	Terminated	1
DB00530	Erlotinib	1	Terminated	1
DB01590	Everolimus	1	Terminated	1
DB17333	Falimarev	1	Active Not Recruiting	1
DB00544	Fluorouracil	1	Terminated	1
DB00441	Gemcitabine	1	Completed	1
DB09054	Idelalisib	1	Terminated	1
DB00619	Imatinib	1	Terminated	1
DB17332	Inalimarev	1	Active Not Recruiting	1
DB06186	Ipilimumab	1	Terminated	1
DB09078	Lenvatinib	1	Terminated	1
DB00650	Leucovorin	1	Terminated	1
DB12130	Lorlatinib	1	Terminated	1
DB00678	Losartan	1	Terminated	1
DB11828	Neratinib	1	Terminated	1
DB09035	Nivolumab	1	Terminated	1
DB09496	Octinoxate	1	Terminated	1
DB09074	Olaparib	1	Terminated	1
DB00526	Oxaliplatin	1	Terminated	1
DB01229	Paclitaxel	1	Completed	1
DB01229	Paclitaxel	1	Terminated	1
DB09073	Palbociclib	1	Terminated	1
DB06603	Panobinostat	1	Terminated	1
DB09037	Pembrolizumab	1	Terminated	1
DB06366	Pertuzumab	1	Terminated	1
DB08901	Ponatinib	1	Terminated	1
DB08896	Regorafenib	1	Terminated	1
DB08877	Ruxolitinib	1	Terminated	1
DB00020	Sargramostim	1	Active Not Recruiting	1
DB00020	Sargramostim	1	Completed	1
DB00877	Sirolimus	1	Terminated	1
DB00398	Sorafenib	1	Terminated	1
DB01268	Sunitinib	1	Terminated	1
DB00820	Tadalafil	1	Completed	1
DB12747	Tertomotide	1	Completed	1
DB08911	Trametinib	1	Terminated	1
DB05773	Trastuzumab emtansine	1	Terminated	1
DB00755	Tretinoin	1	Terminated	1
DB08881	Vemurafenib	1	Terminated	1
DB11581	Venetoclax	1	Terminated	1
DB08828	Vismodegib	1	Terminated	1
DB02546	Vorinostat	1	Terminated	1
DB11105	Benzalkonium	1 / 2	Recruiting	1
DB00441	Gemcitabine	1 / 2	Unknown Status	1
DB16252	Nedisertib	1 / 2	Recruiting	1
DB01229	Paclitaxel	1 / 2	Unknown Status	1
DB11885	Anlotinib	2	Unknown Status	1
DB14547	Chloride ion	2	Active Not Recruiting	1
DB00515	Cisplatin	2	Active Not Recruiting	2
DB00544	Fluorouracil	2	Not Yet Recruiting	1
DB00441	Gemcitabine	2	Active Not Recruiting	2
DB00441	Gemcitabine	2	Not Yet Recruiting	1
DB00441	Gemcitabine	2	Recruiting	1
DB01611	Hydroxychloroquine	2	Active Not Recruiting	1
DB00762	Irinotecan	2	Not Yet Recruiting	1
DB00650	Leucovorin	2	Not Yet Recruiting	1
DB00526	Oxaliplatin	2	Not Yet Recruiting	1
DB01229	Paclitaxel	2	Active Not Recruiting	1
DB01229	Paclitaxel	2	Completed	1
DB01229	Paclitaxel	2	Not Yet Recruiting	1
DB01229	Paclitaxel	2	Recruiting	1
DB01229	Paclitaxel	2	Unknown Status	1
DB09037	Pembrolizumab	2	Not Yet Recruiting	1
DB12257	Platinum	2	Active Not Recruiting	1
DB15043	Toripalimab	2	Unknown Status	1
DB07232	Veliparib	2	Active Not Recruiting	1
DB00460	Verteporfin	2	Not Yet Recruiting	1
DB00441	Gemcitabine	2 / 3	Completed	1
DB00062	Albumin human	3	Unknown Status	1
DB00441	Gemcitabine	3	Unknown Status	1
DB01229	Paclitaxel	3	Unknown Status	1